Annual CFF:
-$1.73B+$186.00M(+9.72%)Summary
- As of today, TEVA annual cash from financing is -$1.73 billion, with the most recent change of +$186.00 million (+9.72%) on December 31, 2024.
- During the last 3 years, TEVA annual cash from financing has risen by +$445.00 million (+20.49%).
- TEVA annual cash from financing is now -106.83% below its all-time high of $25.30 billion, reached on December 31, 2016.
Performance
TEVA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$7.40M+$1.70B(+99.57%)Summary
- As of today, TEVA quarterly cash from financing is -$7.40 million, with the most recent change of +$1.70 billion (+99.57%) on June 30, 2025.
- Over the past year, TEVA quarterly cash from financing has increased by +$958.60 million (+99.23%).
- TEVA quarterly cash from financing is now -100.03% below its all-time high of $25.37 billion, reached on September 30, 2016.
Performance
TEVA Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$2.39B+$958.60M(+28.65%)Summary
- As of today, TEVA TTM cash from financing is -$2.39 billion, with the most recent change of +$958.60 million (+28.65%) on June 30, 2025.
- Over the past year, TEVA TTM cash from financing has dropped by -$182.40 million (-8.27%).
- TEVA TTM cash from financing is now -107.79% below its all-time high of $30.63 billion, reached on September 30, 2016.
Performance
TEVA TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TEVA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +9.7% | +99.2% | -8.3% |
| 3Y3 Years | +20.5% | +97.8% | -18.5% |
| 5Y5 Years | +10.3% | -146.8% | -19.3% |
TEVA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -16.1% | +20.5% | >-9999.0% | +99.6% | -87.0% | +28.6% |
| 5Y | 5-Year | -16.1% | +20.5% | -470.1% | +99.6% | -87.0% | +28.6% |
| All-Time | All-Time | -106.8% | +70.0% | -100.0% | +99.7% | -107.8% | +60.7% |
TEVA Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$7.40M(+99.6%) | -$2.39B(+28.6%) |
| Mar 2025 | - | -$1.71B(-153.1%) | -$3.35B(-93.7%) |
| Dec 2024 | -$1.73B(+9.7%) | -$674.00M(>-9900.0%) | -$1.73B(-6.0%) |
| Sep 2024 | - | $0.00(+100.0%) | -$1.63B(+26.1%) |
| Jun 2024 | - | -$966.00M(-1010.3%) | -$2.21B(-70.4%) |
| Mar 2024 | - | -$87.00M(+84.9%) | -$1.29B(+32.4%) |
| Dec 2023 | -$1.91B(-28.6%) | -$576.00M(0.0%) | -$1.91B(+6.6%) |
| Sep 2023 | - | -$576.00M(-947.3%) | -$2.05B(-7.1%) |
| Jun 2023 | - | -$55.00M(+92.2%) | -$1.91B(+12.9%) |
| Mar 2023 | - | -$706.00M(+0.7%) | -$2.19B(-47.6%) |
| Dec 2022 | -$1.49B(+31.5%) | -$711.00M(-61.6%) | -$1.49B(-16.4%) |
| Sep 2022 | - | -$440.00M(-30.2%) | -$1.28B(+36.6%) |
| Jun 2022 | - | -$338.00M(>-9900.0%) | -$2.01B(-20.1%) |
| Mar 2022 | - | $2.00M(+100.4%) | -$1.68B(+22.8%) |
| Dec 2021 | -$2.17B(-15.2%) | -$501.00M(+57.4%) | -$2.17B(-20.9%) |
| Sep 2021 | - | -$1.18B(>-9900.0%) | -$1.80B(-7.2%) |
| Jun 2021 | - | -$1.00M(+99.8%) | -$1.68B(+0.1%) |
| Mar 2021 | - | -$493.00M(-294.4%) | -$1.68B(+11.0%) |
| Dec 2020 | -$1.89B(+2.1%) | -$125.00M(+88.2%) | -$1.89B(+5.8%) |
| Sep 2020 | - | -$1.06B(>-9900.0%) | -$2.00B(+16.8%) |
| Jun 2020 | - | -$3.00M(+99.6%) | -$2.40B(+1.3%) |
| Mar 2020 | - | -$700.00M(-190.5%) | -$2.44B(-26.5%) |
| Dec 2019 | -$1.93B(+42.5%) | -$241.00M(+83.5%) | -$1.93B(+11.8%) |
| Sep 2019 | - | -$1.46B(-4074.3%) | -$2.18B(-52.9%) |
| Jun 2019 | - | -$35.00M(+81.5%) | -$1.43B(+1.4%) |
| Mar 2019 | - | -$189.00M(+62.1%) | -$1.45B(+56.8%) |
| Dec 2018 | -$3.35B(+41.7%) | -$499.00M(+29.2%) | -$3.35B(+37.5%) |
| Sep 2018 | - | -$705.00M(-1158.9%) | -$5.36B(+2.2%) |
| Jun 2018 | - | -$56.00M(+97.3%) | -$5.48B(+9.8%) |
| Mar 2018 | - | -$2.09B(+16.6%) | -$6.07B(-5.6%) |
| Dec 2017 | -$5.75B(-122.7%) | -$2.51B(-203.8%) | -$5.75B(-45.8%) |
| Sep 2017 | - | -$825.00M(-26.7%) | -$3.94B(-117.7%) |
| Jun 2017 | - | -$651.00M(+63.2%) | $22.25B(-4.0%) |
| Mar 2017 | - | -$1.77B(-152.2%) | $23.18B(-8.1%) |
| Dec 2016 | $25.30B(+426.6%) | -$701.00M(-102.8%) | $25.22B(-17.7%) |
| Sep 2016 | - | $25.37B(+8993.9%) | $30.63B(+634.4%) |
| Jun 2016 | - | $279.00M(+4.5%) | $4.17B(-16.2%) |
| Mar 2016 | - | $267.00M(-94.3%) | $4.98B(+3.6%) |
| Dec 2015 | $4.80B(+302.3%) | $4.71B(+532.6%) | $4.80B(+1055.3%) |
| Sep 2015 | - | -$1.09B(-200.3%) | -$503.00M(-295.0%) |
| Jun 2015 | - | $1.09B(+1068.8%) | $258.00M(+115.7%) |
| Mar 2015 | - | $93.00M(+115.7%) | -$1.65B(+30.6%) |
| Dec 2014 | -$2.38B(+38.8%) | -$593.00M(-80.2%) | -$2.38B(-0.5%) |
| Sep 2014 | - | -$329.00M(+59.8%) | -$2.36B(-5.9%) |
| Jun 2014 | - | -$819.00M(-29.2%) | -$2.23B(-2.1%) |
| Mar 2014 | - | -$634.00M(-9.0%) | -$2.19B(+43.7%) |
| Dec 2013 | -$3.88B(-132.2%) | -$581.44M(-195.5%) | -$3.88B(-27.6%) |
| Sep 2013 | - | -$196.80M(+74.6%) | -$3.04B(+11.3%) |
| Jun 2013 | - | -$773.83M(+66.8%) | -$3.43B(-0.4%) |
| Mar 2013 | - | -$2.33B(-1003.8%) | -$3.42B(-104.3%) |
| Dec 2012 | -$1.67B | $257.76M(+144.2%) | -$1.67B(-178.0%) |
| Sep 2012 | - | -$582.76M(+23.4%) | $2.14B(-37.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | -$760.62M(-29.8%) | $3.45B(-2.0%) |
| Mar 2012 | - | -$586.20M(-114.4%) | $3.52B(+6.1%) |
| Dec 2011 | $3.32B(+479.9%) | $4.07B(+464.4%) | $3.32B(+350.2%) |
| Sep 2011 | - | $721.36M(+204.7%) | -$1.33B(+41.3%) |
| Jun 2011 | - | -$688.95M(+12.5%) | -$2.26B(-5530.2%) |
| Mar 2011 | - | -$787.03M(-37.8%) | -$40.13M(-107.0%) |
| Dec 2010 | $572.04M(+125.3%) | -$571.19M(-168.8%) | $572.04M(-36.1%) |
| Sep 2010 | - | -$212.47M(-113.9%) | $894.66M(+252.3%) |
| Jun 2010 | - | $1.53B(+975.3%) | $253.93M(+110.5%) |
| Mar 2010 | - | -$174.86M(+29.7%) | -$2.41B(-6.7%) |
| Dec 2009 | -$2.26B(-267.3%) | -$248.57M(+70.9%) | -$2.26B(-3401.8%) |
| Sep 2009 | - | -$853.20M(+24.6%) | -$64.48M(-109.1%) |
| Jun 2009 | - | -$1.13B(-4528.0%) | $707.57M(-41.8%) |
| Mar 2009 | - | -$24.45M(-101.3%) | $1.22B(-10.0%) |
| Dec 2008 | $1.35B(+475.4%) | $1.94B(+2496.5%) | $1.35B(+280.7%) |
| Sep 2008 | - | -$81.15M(+87.0%) | -$747.68M(+17.9%) |
| Jun 2008 | - | -$624.17M(-660.9%) | -$910.72M(-219.8%) |
| Mar 2008 | - | $111.29M(+172.4%) | -$284.81M(+20.9%) |
| Dec 2007 | -$359.81M(-117.9%) | -$153.64M(+37.1%) | -$360.16M(+33.8%) |
| Sep 2007 | - | -$244.19M(>-9900.0%) | -$543.88M(+1.0%) |
| Jun 2007 | - | $1.73M(-95.2%) | -$549.22M(-1.9%) |
| Mar 2007 | - | $35.94M(+110.7%) | -$539.16M(-126.8%) |
| Dec 2006 | $2.01B(+742.7%) | -$337.37M(-35.2%) | $2.01B(-25.5%) |
| Sep 2006 | - | -$249.53M(-2215.5%) | $2.70B(-3.4%) |
| Jun 2006 | - | $11.80M(-99.5%) | $2.80B(+8.0%) |
| Mar 2006 | - | $2.59B(+636.3%) | $2.59B(+927.1%) |
| Dec 2005 | -$313.36M(-136.7%) | $351.63M(+329.4%) | -$313.36M(+59.1%) |
| Sep 2005 | - | -$153.29M(+21.7%) | -$765.39M(-7.4%) |
| Jun 2005 | - | -$195.64M(+38.1%) | -$712.88M(-30.1%) |
| Mar 2005 | - | -$316.06M(-214.8%) | -$547.92M(-164.2%) |
| Dec 2004 | $852.81M(+2797.3%) | -$100.39M(+0.4%) | $852.81M(-13.6%) |
| Sep 2004 | - | -$100.77M(-228.4%) | $987.03M(-9.3%) |
| Jun 2004 | - | -$30.69M(-102.8%) | $1.09B(-2.7%) |
| Mar 2004 | - | $1.08B(+3105.9%) | $1.12B(+3205.9%) |
| Dec 2003 | $29.43M(-91.3%) | $33.83M(+233.8%) | $33.83M(-90.3%) |
| Dec 2002 | $338.13M(+26.8%) | - | - |
| Jun 2002 | - | -$25.29M(+48.8%) | $349.37M(+3.0%) |
| Mar 2002 | - | -$49.40M(-255.8%) | $339.11M(+27.1%) |
| Dec 2001 | $266.72M(+0.4%) | -$13.88M(-103.2%) | $266.72M(-4.9%) |
| Sep 2001 | - | $437.95M(+1331.5%) | $280.60M(+278.3%) |
| Jun 2001 | - | -$35.56M(+70.8%) | -$157.35M(-29.2%) |
| Mar 2001 | - | -$121.79M | -$121.79M |
| Dec 2000 | $265.71M(-57.8%) | - | - |
| Dec 1999 | $628.99M(+200.4%) | - | - |
| Dec 1998 | $209.39M(+255.2%) | - | - |
| Dec 1997 | -$134.93M(-202.6%) | - | - |
| Dec 1996 | $131.51M(+267.2%) | - | - |
| Dec 1995 | $35.81M(-11.2%) | - | - |
| Dec 1994 | $40.33M(-14.4%) | - | - |
| Dec 1993 | $47.13M(+77.8%) | - | - |
| Dec 1992 | $26.50M(-24.7%) | - | - |
| Dec 1991 | $35.20M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cash from financing?
- What is the all-time high annual cash from financing for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual cash from financing year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly cash from financing year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM cash from financing?
- What is the all-time high TTM cash from financing for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM cash from financing year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cash from financing?
The current annual cash from financing of TEVA is -$1.73B
What is the all-time high annual cash from financing for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cash from financing is $25.30B
What is Teva Pharmaceutical Industries Limited annual cash from financing year-on-year change?
Over the past year, TEVA annual cash from financing has changed by +$186.00M (+9.72%)
What is Teva Pharmaceutical Industries Limited quarterly cash from financing?
The current quarterly cash from financing of TEVA is -$7.40M
What is the all-time high quarterly cash from financing for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cash from financing is $25.37B
What is Teva Pharmaceutical Industries Limited quarterly cash from financing year-on-year change?
Over the past year, TEVA quarterly cash from financing has changed by +$958.60M (+99.23%)
What is Teva Pharmaceutical Industries Limited TTM cash from financing?
The current TTM cash from financing of TEVA is -$2.39B
What is the all-time high TTM cash from financing for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM cash from financing is $30.63B
What is Teva Pharmaceutical Industries Limited TTM cash from financing year-on-year change?
Over the past year, TEVA TTM cash from financing has changed by -$182.40M (-8.27%)